Bayer, TAP “Average Sales Price” To Replace Medicare AWP In House Bill

The House Energy & Commerce Committee is drafting legislation to use the "average sales price" formula negotiated by Bayer and TAP in recent settlements of False Claims Act cases as a replacement for the "average wholesale price" payment methodology for Medicare

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet